Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Conduit SE"'
Autor:
Conduit SE; Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK. s.conduit@ucl.ac.uk., Pearce W; Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK., Bhamra A; Proteomics Research Translational Technology Platform, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK., Bilanges B; Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK., Bozal-Basterra L; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain.; Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), 28029, Madrid, Spain., Foukas LC; Institute of Healthy Ageing, Department of Genetics, Evolution and Environment, University College London, London, WC1E 6BT, UK., Cobbaut M; Signalling and Structural Biology laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Castillo SD; Endothelial Pathobiology and Microenvironment, Josep Carreras Leukaemia Research Institute, Barcelona, Spain., Danesh MA; Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK., Adil M; Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK., Carracedo A; Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain.; Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), 28029, Madrid, Spain.; Translational Prostate Cancer Research Laboratory, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; IKERBASQUE, Basque Foundation for Science, 48009, Bilbao, Spain.; Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), P.O. Box 644, E-48080, Bilbao, Spain., Graupera M; Centro de Investigación Biomédica En Red de Cáncer (CIBERONC), 28029, Madrid, Spain.; Endothelial Pathobiology and Microenvironment, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Pg. Lluís Companys 23, Barcelona, Spain., McDonald NQ; Signalling and Structural Biology laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.; Institute of Structural and Molecular Biology, School of Natural Sciences, Birkbeck College, Malet Street, London, WC1E 7HX, UK., Parker PJ; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.; King's College London, Guy's Campus, London, UK., Cutillas PR; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK., Surinova S; Proteomics Research Translational Technology Platform, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK., Vanhaesebroeck B; Cell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK. bart.vanh@ucl.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 21; Vol. 15 (1), pp. 7181. Date of Electronic Publication: 2024 Aug 21.
Autor:
Tham MS; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Cottle DL; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. denny.cottle@monash.edu.; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. denny.cottle@monash.edu., Zylberberg AK; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Short KM; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Jones LK; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Chan P; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Conduit SE; Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Dyson JM; Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Mitchell CA; Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Smyth IM; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. ian.smyth@monash.edu.; Department of Anatomy and Developmental Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. ian.smyth@monash.edu.; Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. ian.smyth@monash.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Jan 08; Vol. 15 (1), pp. 371. Date of Electronic Publication: 2024 Jan 08.
Autor:
Gong GQ; Cell Signalling, Cancer Institute, University College London, London, UK., Bilanges B; Cell Signalling, Cancer Institute, University College London, London, UK., Allsop B; Drug Discovery Group, Translational Research Office, University College London, London, UK., Masson GR; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.; Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, UK., Roberton V; UCL Centre for Nerve Engineering, UCL School of Pharmacy, University College London, London, UK., Askwith T; Drug Discovery Group, Translational Research Office, University College London, London, UK., Oxenford S; Drug Discovery Group, Translational Research Office, University College London, London, UK., Madsen RR; Cell Signalling, Cancer Institute, University College London, London, UK., Conduit SE; Cell Signalling, Cancer Institute, University College London, London, UK., Bellini D; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Fitzek M; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, Macclesfield, UK., Collier M; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, Macclesfield, UK., Najam O; The Hatter Cardiovascular Institute, University College London, London, UK., He Z; The Hatter Cardiovascular Institute, University College London, London, UK., Wahab B; Medicines Discovery Institute, School of Biosciences, Cardiff University, Cardiff, UK., McLaughlin SH; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Chan AWE; Wolfson Institute for Biomedical Research, University College London, London, UK., Feierberg I; Molecular AI, Discovery Sciences, R&D, AstraZeneca, Waltham, MA, USA., Madin A; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Morelli D; Cell Signalling, Cancer Institute, University College London, London, UK., Bhamra A; Proteomics Research Translational Technology Platform, Cancer Institute, University College London, London, UK., Vinciauskaite V; Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, UK., Anderson KE; Signalling Programme, Babraham Institute, Cambridge, UK., Surinova S; Proteomics Research Translational Technology Platform, Cancer Institute, University College London, London, UK., Pinotsis N; Institute of Structural and Molecular Biology, Birkbeck College, London, UK., Lopez-Guadamillas E; Cell Signalling, Cancer Institute, University College London, London, UK., Wilcox M; UCL Centre for Nerve Engineering, UCL School of Pharmacy, University College London, London, UK., Hooper A; Drug Discovery Group, Translational Research Office, University College London, London, UK., Patel C; Drug Discovery Group, Translational Research Office, University College London, London, UK., Whitehead MA; Cell Signalling, Cancer Institute, University College London, London, UK., Bunney TD; Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UK., Stephens LR; Signalling Programme, Babraham Institute, Cambridge, UK., Hawkins PT; Signalling Programme, Babraham Institute, Cambridge, UK., Katan M; Institute of Structural and Molecular Biology, Division of Biosciences, University College London, London, UK., Yellon DM; The Hatter Cardiovascular Institute, University College London, London, UK., Davidson SM; The Hatter Cardiovascular Institute, University College London, London, UK., Smith DM; Emerging Innovations, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK., Phillips JB; UCL Centre for Nerve Engineering, UCL School of Pharmacy, University College London, London, UK., Angell R; Drug Discovery Group, Translational Research Office, University College London, London, UK.; Medicines Discovery Institute, School of Biosciences, Cardiff University, Cardiff, UK., Williams RL; Medical Research Council Laboratory of Molecular Biology, Cambridge, UK., Vanhaesebroeck B; Cell Signalling, Cancer Institute, University College London, London, UK. bart.vanh@ucl.ac.uk.
Publikováno v:
Nature [Nature] 2023 Jun; Vol. 618 (7963), pp. 159-168. Date of Electronic Publication: 2023 May 24.
Autor:
Conduit SE; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia., Davies EM; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia., Fulcher AJ; Monash Micro Imaging, Monash University, Clayton, VIC, Australia., Oorschot V; Monash Ramaciotti Centre for Structural Cryo-Electron Microscopy, Monash University, Clayton, VIC, Australia., Mitchell CA; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia.
Publikováno v:
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 Apr 30; Vol. 9, pp. 634649. Date of Electronic Publication: 2021 Apr 30 (Print Publication: 2021).
Autor:
Conduit SE; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6BT, U.K., Vanhaesebroeck B; UCL Cancer Institute, University College London, 72 Huntley Street, London WC1E 6BT, U.K.
Publikováno v:
The Biochemical journal [Biochem J] 2020 Sep 30; Vol. 477 (18), pp. 3541-3565.
Autor:
Conduit SE; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia., Davies EM; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia., Ooms LM; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia., Gurung R; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia., McGrath MJ; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia., Hakim S; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia., Cottle DL; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Department of Anatomy and Developmental Biology, Monash University, Clayton 3800, Australia., Smyth IM; Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Department of Anatomy and Developmental Biology, Monash University, Clayton 3800, Australia., Dyson JM; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia., Mitchell CA; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton 3800, Australia.
Publikováno v:
Human molecular genetics [Hum Mol Genet] 2020 Jan 01; Vol. 29 (1), pp. 31-48.
Autor:
Conduit SE; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Hakim S; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Feeney SJ; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Ooms LM; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Dyson JM; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Abud HE; Cancer Program, Monash Biomedicine Discovery Institute, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia., Mitchell CA; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.
Publikováno v:
Human molecular genetics [Hum Mol Genet] 2019 Jan 15; Vol. 28 (2), pp. 230-244.
Autor:
Conduit SE; Department of Biochemistry and Molecular Biology, Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia., Ramaswamy V; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada., Remke M; The Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada., Watkins DN; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.; St. Vincent's Clinical School, Faculty of Medicine, UNSW, Darlinghurst, New South Wales, Australia.; Department of Thoracic Medicine, St Vincent's Hospital, Darlinghurst, New South Wales, Australia., Wainwright BJ; Division of Molecular Genetics and Development, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Taylor MD; The Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada., Mitchell CA; Department of Biochemistry and Molecular Biology, Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia., Dyson JM; Department of Biochemistry and Molecular Biology, Cancer Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.
Publikováno v:
Oncogene [Oncogene] 2017 Oct 26; Vol. 36 (43), pp. 5969-5984. Date of Electronic Publication: 2017 Jun 26.
Autor:
Carroll B; Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK bernadette.carroll@ncl.ac.uk., Nelson G; Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK., Rabanal-Ruiz Y; Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK., Kucheryavenko O; Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK., Dunhill-Turner NA; Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK., Chesterman CC; Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK., Zahari Q; Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK., Zhang T; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, UK., Conduit SE; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Mitchell CA; Cancer Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia., Maddocks ODK; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, UK., Lovat P; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., von Zglinicki T; Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK., Korolchuk VI; Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK viktor.korolchuk@ncl.ac.uk.
Publikováno v:
The Journal of cell biology [J Cell Biol] 2017 Jul 03; Vol. 216 (7), pp. 1949-1957. Date of Electronic Publication: 2017 May 31.
Autor:
Dyson JM; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia., Conduit SE; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia., Feeney SJ; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia., Hakim S; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia., DiTommaso T; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia., Fulcher AJ; Monash Micro Imaging, Monash University, Clayton, Victoria 3800, Australia., Sriratana A; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia., Ramm G; Monash Micro Imaging, Monash University, Clayton, Victoria 3800, Australia., Horan KA; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia., Gurung R; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia., Wicking C; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia., Smyth I; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia.; Development and Stem Cells Program, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia., Mitchell CA; Cancer Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia christina.mitchell@monash.edu.
Publikováno v:
The Journal of cell biology [J Cell Biol] 2017 Jan 02; Vol. 216 (1), pp. 247-263. Date of Electronic Publication: 2016 Dec 20.